Patients with a history of pancreatitis, gallbladder disease, or severe gastroparesis may require careful consideration of risks versus benefits
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP1 trial extension
As highlighted in a recent review, while GLP-1RAs show potential in treating SLE, further prospective investigations are needed to determine if they pose a risk of triggering autoimmune activity and whether their advantages in SLE outweigh such risks [292]
A reasonable framework is to get a full baseline panel before you start, then recheck the markers that move
The direct regulation of GLP-1 on insulin expression is significant for type 2 diabetes (T2D) patients with simple glucose tolerance but normal insulin secretion ( 2 Peptide-based GLP-1 derivatives and small molecule compounds of GLP-1RA There are two main categories of GLP-1 receptor agonists, small molecule compounds and peptide-based GLP-1 derivatives as shown in Figure 1 , including exenatide, liraglutide, dulaglutide, etc